Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006418 · ClinicalTrials.gov registry record
Molecular Genetics of Schizophrenia
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 10,800
- Enrollment target
NCT00006418: Completed study, sponsored by Endeavor Health.
NCT00006418 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 10,800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006418 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 10,800 participants
- Enrollment target
Study Summary
This study will create a DNA collection with blood samples from families with at least two siblings who have schizophrenia symptoms. This collection will help scientists identify genes that predispose people to schizophrenia.
Interventions
- PROCEDURE DNA collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,800 participants |
| Start Date | 2003-09 |
| Est. Completion | 2007-08 |
What the finished NCT00006418 record still lists
NCT00006418 is an observational study that tracks outcomes without assigning an intervention. Its 10,800 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which DNA collection is the first listed.
NCT00006418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006418 about?
NCT00006418 is a clinical study titled "Molecular Genetics of Schizophrenia". This study will create a DNA collection with blood samples from families with at least two siblings who have schizophrenia symptoms. This collection will help scientists identify genes that predispose people to schizophrenia.
What is the current status of trial NCT00006418?
This trial is currently completed. The enrollment target is 10,800 participants. The study started on 2003-09. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00006418?
The interventions under investigation include: DNA collection (PROCEDURE).
Who is sponsoring clinical trial NCT00006418?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia